Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030


Caramel Ingredients Market Growth & Trends

The global caramel ingredients market size is expected to reach USD 4.75 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.1% from 2025 to 2030. Rising use of caramel in the food and beverages industry, particularly for bakery, confectionery, and beverage products, is the main factor driving the market. Changing consumer tastes, preferences, lifestyle, and incomes has played a key role in influencing F&B trends. Popularity of items such as salted caramel chocolates, caramel glazed muffins, and caramel lattes are driven by consumers and this poses as a lucrative opportunity for players.

On the basis of form, the market includes liquid, granular, and solid ingredients. Liquid ingredients held the largest share of just under 60.5% in 2024, fueled by extensive usage in the beverage industry for alcoholic and non-alcoholic drinks. Based on end use, the confectionery segment enjoys the dominant share and is expected to account for a share of over 28.63% by 2030. Widespread consumption of caramel chocolates and candy bars across the globe is a key factor driving segment growth. The beverages segment, on the other hand, is projected to register the fastest growth by the end of the forecast period, with most soda and cola companies using this ingredient in their products.

By application, the caramel ingredients market has been segmented into coloring, topping, flavoring, and others. While coloring emerged as the dominant segment in terms of revenue, the topping segment is anticipated to witness the strongest growth over the forecast period. An increasing number of bakeries, confectionery stores, and coffee shops have been using caramel drizzles and toppings on their menu items. For instance, McDonald’s Canada released a new fall-themed beverage and muffin in August 2019. The Caramel Pumpkin Spice Latte is a play on the conventional autumn favorite and is topped off with a smooth caramel pumpkin spice syrup. What makes the Caramel Apple Oat Muffin a crowd-favorite is a crunchy caramelized glaze on top.

There are several key players operating in the market, such as Cargill, Inc.; Nestlé S.A.; Mars Inc.; Kerry Group; Ferrero SpA; Sensient Technologies Corporation; Goetze’s Candy Company, Inc.; Frito-Lay; DDW The Color House; Sethness-Roquette Caramel Color; Bakels Worldwide; Alvin Caramel Colours; and Metarom. Players have been investing in various expansion strategies in order to gain a larger customer base and to strengthen their foothold in the global market. For instance, in September 2018, Metarom rolled out its plans to capitalize on the strong growth in South East Asian markets, beginning with setting up a new sales unit in Malaysia. The company also plans to establish an independent factory close to Kuala Lumpur, which will include an R&D food tech lab and a flavor creation lab.

Caramel Ingredients Market Report Highlights
  • The global caramel ingredients market size was valued at USD 3.19 billion in 2024 and is expected to expand at a CAGR of 7.1% from 2025 to 2030
  • Based on form, granulated ingredients are expected to witness the fastest growth over the forecast period due to widespread application in the food industry as a topping and flavoring agent
  • By application, coloring generated the highest value of USD 1.12 billion in 2024 owing to increased usage of caramelizing colors in products such as tea, lemonade, fruit-based beverages, and beer
  • On the basis of end use, the confectionery industry accounted for the largest share of 28.63% in 2024 due to the application of caramel ingredients in chocolates and candies. On the other hand, the beverage sector is expected to register the highest CAGR of 7.1% over the forecast period
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Neuralgia Treatment Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Neuralgia Treatment Market: Treatment Business Analysis
4.1. Treatment Market Share, 2024 & 2030
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Drug Based
4.4.1. Drug based market, 2018 - 2030 (USD Million)
4.4.2. Anticonvulsant medicines
4.4.2.1. Anticonvulsant medicines market, 2018 - 2030 (USD Million)
4.4.3. Tricyclic antidepressants
4.4.3.1. Tricyclic antidepressants market, 2018 - 2030 (USD Million)
4.5. Surgery
4.5.1. Surgery market, 2018 - 2030 (USD Million)
4.5.2. Radiofrequency Thermal Lesioning
4.5.2.1. Radiofrequency thermal lesioning market, 2018 - 2030 (USD Million)
4.5.3. Stereotactic Radiosurgery
4.5.3.1. Stereotactic radiosurgery market, 2018 - 2030 (USD Million)
4.5.4. Microvascular Decompression
4.5.4.1. Microvascular decompression market, 2018 - 2030 (USD Million)
4.5.5. Others
4.5.5.1. Others market, 2018 - 2030 (USD Million)
Chapter 5. Neuralgia Treatment Market: End Use Business Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospital & Clinics
5.4.1. Hospital & clinics market, 2018 - 2030 (USD Million)
5.5. Ambulatory Surgery Centers
5.5.1. Ambulatory surgery centers market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others market, 2018 - 2030 (USD Million)
Chapter 6. Neuralgia Treatment Market: Country Estimates & Trend Analysis by Product and Technology
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Russia
6.5.7.1. Key country dynamic
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Russia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamic
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Denmark neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key country dynamic
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Sweden neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.10. Norway
6.5.10.1. Key country dynamic
6.5.10.2. Regulatory framework
6.5.10.3. Competitive insights
6.5.10.4. Norway neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamic
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamic
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Australia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamic
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. Thailand neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. South Korea
6.6.7.1. Key country dynamic
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. South Korea neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamic
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamic
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamic
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamic
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. GSK plc.
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Pfizer Inc.
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Novartis AG
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Biogen
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Zydus Group (Cadila Healthcare Limited)
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. H. Lundbeck A/S
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings